Literature DB >> 13924349

The glyoxalase content of human erythrocytes and leukocytes.

W N VALENTINE, K R TANAKA.   

Abstract

Entities:  

Keywords:  ERYTHROCYTES/metabolism; HYDRASES/blood; LEUKOCYTES/metabolism

Mesh:

Substances:

Year:  1961        PMID: 13924349     DOI: 10.1159/000206665

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


× No keyword cloud information.
  8 in total

1.  STUDIES ON CHROMATED ERYTHROCYTES. EFFECT OF SODIUM CHROMATE ON ERYTHROCYTE GLUTATHIONE REDUCTASE.

Authors:  G A KOUTRAS; M HATTORI; A S SCHNEIDER; F G EBAUGH; W N VALENTINE
Journal:  J Clin Invest       Date:  1964-02       Impact factor: 14.808

2.  [Enzyme pathology of the blood cells].

Authors:  K U BLUM
Journal:  Blut       Date:  1962-06

3.  Proceedings: The effects of postaglandin synthesis inhibitors on renal blood flow distribution within the kidney.

Authors:  L J Beilin; J Bhattacharya
Journal:  J Physiol       Date:  1976-03       Impact factor: 5.182

4.  Blood cell enzymes in translocation Down's syndrome.

Authors:  R S Sparkes; M A Baughan
Journal:  Am J Hum Genet       Date:  1969-09       Impact factor: 11.025

5.  Human red cell glyoxalase I polymorphism.

Authors:  C W Parr; I A Bagster; S G Welch
Journal:  Biochem Genet       Date:  1977-02       Impact factor: 1.890

6.  Absent thumbs with a ring D2 chromosome: a new deletion syndrome.

Authors:  R S Sparkes; R E Carrel; S W Wright
Journal:  Am J Hum Genet       Date:  1967-09       Impact factor: 11.025

7.  A new rare variant of the glyoxalase I system of the red cell: GLO-Sicily.

Authors:  M Beretta; G Schilirò; A Russo; G Barbujani; P Mazzetti; G Russo; I Barrai
Journal:  Am J Hum Genet       Date:  1983-09       Impact factor: 11.025

8.  A new variant glyoxalase I allele that is readily detectable in stimulated lymphocytes and lymphoblastoid cell lines but not in circulating lymphocytes or erythrocytes.

Authors:  P Kavathas; R DeMars
Journal:  Am J Hum Genet       Date:  1981-11       Impact factor: 11.025

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.